ADMS stock news

NEW YORK, Feb. 5, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Adamas Pharmaceuticals, Inc. between August 8, 2017 and September 30, 2019, inclusive (the "Class Period"), of the important February 10, 2020 lead plaintiff… Read more
NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action filed on behalf of investors that purchased or acquired the securities of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (NASDAQ: ADMS) between August 8, 2017, and September 30, 2019, inclusive (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of Read more

GE T&D bags Rs 173 cr JKPDD contract

11:17am, Thursday, 23'rd Jan 2020
GE T&D India on Thursday said it bagged a Supervisory Control and Data Acquisition (SCADA) and Advanced Distribution Management Solution (ADMS) project by the Jammu & Kashmir Power Development Department (JKPDD) worth Rs 173 crore for distribution operations in the cities of Jammu and Srinagar.The order won through a competitive bidding process includes a 5-year maintenance services contract and supply and integration of a host of solutions in the overall distribution network in the two cities, an official statement said.The technology solution being executed for this project is used mainly for 24x7 power supply, reduction of power losses and real-time data monitoring and control of distribution network from a centralised place.This will determine the setting up of reliable systems for system control/data collection and adoption of Information Technology in the area of energy accounting.SCADA technology reduces aggregate technical and commercial (AT&C) losses and enables real-time monitoring and control of the electric distribution network, handling of loads during load shedding and restoration and plugging of pilferage points, it said. Read more
NEW YORK, Jan. 04, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Adamas Pharmaceuticals, Inc. between August 8, 2017 and September 30,… Read more
LOS ANGELES--(BUSINESS WIRE)---- $ADMS--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. Read more
LOS ANGELES--(BUSINESS WIRE)---- $ADMS #ADMS--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. Read more
REUTERS: Adamas Pharmaceuticals Inc said on Tuesday its drug to treat walking impairment in patients with multiple sclerosis did not show the … Read more
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Adamas Pharmaceuticals Inc (NASDAQ:ADMS). Is Adamas Pharmaceuticals Read more
NEW YORK, Dec. 14, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Adamas… | December 14, 2019 Read more
Glancy Prongay & Murray LLP , a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that acquired Adamas Pharmaceuticals, Inc. … | December 13, 2019 Read more
LOS ANGELES--(BUSINESS WIRE)---- $ADMS--Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Adamas Pharmaceuticals, Inc. Investors Read more
SAN DIEGO & EMERYVILLE, Calif.--(BUSINESS WIRE)---- $ADMS #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between August 8, 2017 and September 30, 2019. Adamas is a commercial stage pharmaceutical company that specializes in developing drug treatment therapies for chronic neurologic disorders. Adamas' primary product is GOCOVRI. If you suffered a Read more
LOS ANGELES--(BUSINESS WIRE)---- $ADMS--Glancy Prongay & Murray LLP Announces Investigation on Behalf of Adamas Pharmaceuticals, Inc. Investors Read more
NEW YORK, Dec. 12, 2019 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Adamas Pharmaceuticals, Inc. ("Adamas" or the "Company")… Read more
LOS ANGELES--(BUSINESS WIRE)---- $ADMS #ADMS--IMPORTANT INVESTOR ALERT: The Schall Law Firm Has Filed a Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT